Back

Atrioventricular node ablation and CRT is the future.

29 August 2022 (09:24 - 09:42)
Organised by:
Congress Presentation Part of: The management challenge of atrial fibrillation in HFrEF and HFpEF Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Gerhard Hindricks

Charite University Hospital, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Atrial fibrillation and heart failure: epidemiology, risk factors and prevention.
Professor L. Kober (Copenhagen, DK)
Slides Video
Presentation thumbnail
Rate control first for most atrial fibrillation patients: beta-blocker and/or digitalis?
Professor D. Kotecha (Birmingham, GB)
Slides Video
Presentation thumbnail
How good is pulmonary vein isolation in atrial fibrillation with heart failure?
Professor T. Potpara (Belgrade, RS)
Slides Video
Presentation thumbnail
The management challenge of atrial fibrillation in HFrEF and HFpEF – discussion.
Doctor E. O'Meara (Montreal, CA)
Slides Video

Access the full session

Session thumbnail
The management challenge of atrial fibrillation in HFrEF and HFpEF
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 09:24 CET
You may be interested in
thumbnail
Congress Presentation
Atrioventricular node ablation: when it is appropriate
19 May 2025
thumbnail
Congress Session
Overcoming the growing challenge of advanced heart failure
17 April 2023
thumbnail
Congress Session
New strategies to manage AF
27 August 2022
thumbnail
Congress Session
Atrial fibrillation and heart failure with preserved ejection fraction (HFpEF): managing a common combination
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources